Discontinuation of lipid-modifying agents and failure to achieve target LDL cholesterol levels across cardiovascular risk groups.
Orman Z, Koh JW, Trin C, Ademi Z, Zomer E, Green S, Berkovic D, Ilomaki J, Bell JS, Liew D, Reid CM, Lybrand S, Schoeninger B, Talic S.
Orman Z, et al. Among authors: bell js.
J Clin Lipidol. 2025 Jul-Aug;19(4):835-843. doi: 10.1016/j.jacl.2025.06.010. Epub 2025 Jun 23.
J Clin Lipidol. 2025.
PMID: 40675914
Free article.